Novartis AG-RegNVSEF
13F holders, Q3 2024 (September 30)2holders −1
0new positions
1sold out
$115.12avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Novartis AG-Reg (NVSEF) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Boston Common Asset Management, LLC ($21.6M) and Partners Capital Investment Group, LLP ($4.7M).
- Company
- Novartis AG-Reg
- CUSIP
- H5820Q150
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $10.0M |
All 13F filers, Q2 2024 → Q3 2024: 16,562 shares bought and 98,534 shares sold, net −81,972 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Boston Common Asset Management, LLC | 0.56% | Add +9.7% | 187,433 | $21.6M |
| Partners Capital Investment Group, LLP | 0.07% | Reduce -10.4% | 40,696 | $4.7M |
"% of holder's portfolio" is NVSEF's weight in each manager's 13F, not the share of Novartis AG-Reg the manager owns.